Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol

INTRODUCTION: This article describes the protocol of an Ebola vaccine clinical trial which investigates the safety and immunogenicity of a two-dose prophylactic Ebola vaccine regimen comprised of two Ebola vaccines (Ad26.ZEBOV and MVA-BN-Filo) administered 56 days apart, followed by a booster vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Larivière, Ynke, Zola, Trésor, Stoppie, Elke, Maketa, Vivi, Matangila, Junior, Mitashi, Patrick, De Bie, Jessie, Muhindo-Mavoko, Hypolite, Van geertruyden, Jean-Pierre, Van Damme, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479954/
https://www.ncbi.nlm.nih.gov/pubmed/34588237
http://dx.doi.org/10.1136/bmjopen-2020-046835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479954/
https://www.ncbi.nlm.nih.gov/pubmed/34588237
http://dx.doi.org/10.1136/bmjopen-2020-046835

Ejemplares similares